EGFR-TKI耐性NSCLCにおける免疫療法:メカニズム,治療戦略,新たな課題
Shuyi Hu1, Xinhong Shi1, Qin Hu1
1Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Biochimica et biophysica acta. Reviews on cancer
|February 17, 2026
まとめ
Epidermal成長因子受容体 (EGFR) 変異は,非小細胞肺がん (NSCLC) で一般的です. このレビューは,EGFR変異性NSCLCのEGFRチロシンキナーゼ阻害剤 (EGFR-TKI) と免疫療法で進行する治療戦略をカバーしています.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- がん研究 がん研究
背景:
- 皮膜成長因子受容体 (EGFR) 変異は,非小細胞肺がん (NSCLC) の主要な原動力である.
- 第3世代のEGFRチロシンキナーゼ阻害剤 (EGFR-TKI) はEGFR変異性NSCLCの主要な治療法である.
- 腫瘍の微小環境を理解することは,治療の有効性にとって極めて重要です.
研究 の 目的:
- EGFR-TKI治療の後に進行するNSCLC患者の治療選択肢を見直す.
- この集団における免疫療法耐性メカニズムと管理戦略を探求する.
- EGFR-TKIと免疫療法の併用後の進行パターンと後の治療法について議論する.
主な方法:
- 現在の治療法の選択肢を体系的に検討する.
- 免疫療法に対する耐性メカニズムの概要.
- 進行パターンの議論と,その後の治療法.
主要な成果:
- EGFR-TKIはEGFR変異性NSCLCにとって不可欠である.
- EGFR-TKIに対する抵抗は,代替戦略を探求することを必要としています.
- 免疫療法に対する耐性メカニズムには,特定の管理方法が必要です.
結論:
- 耐性,分子プロファイリング,および進行パターンに基づく治療アルゴリズムは,臨床的決定を導くことができます.
- EGFR変異性NSCLCの効果的な管理には,配列療法に対する包括的なアプローチが必要です.
- EGFR-TKIと免疫療法の両方に対する耐性を克服するためのさらなる研究は正当化されています.
キーワード:
EGFRは,EGFRに拠点を置いている.EGFR-TKIは,土耳其に拠点を置いている.免疫ベースのセラピーは免疫療法に対する耐性があります.NSCLCLCは,NSCLCLCは,NSCLCLCは,NSCLCLCは,NSCLCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCは,NSCLCはさらに関連する動画
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.4K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.8K
関連する概念動画
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
02:38Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K